GGrantIndex
← Search

0629GCC: A PHASE I, OPEN-LABEL, MULTI-CENTER, DOSE-ESCALATION STUDY TO ASSESS SL

$3,156M01FY2007RRNIH

University Of Maryland Baltimore, Baltimore MD

Investigators

Linked publications & trials

View original record on NIH RePORTER →